A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000000975
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)